Episode 319: Listener questions and some questionable answers – PART IV

In episode 319, Mike and James begin questioning the number of questions they are having to answer but plough forward and talk about confidence intervals, anticoagulation bridging, hormone replacement and finally bring it all home with comments on DRE. 

Show notes Read more »

Episode 318: Listener questions and some questionable answers – PART III

In episode 318, Mike and James attempt to answer even more questions. We run the spectrum from steroid injections, to repeat bone density measurements, to vortioxetine, generic drugs, and sitagliptin. Bottom line - please stop going to industry sponsored CME.

Show notes

1) Generic drugs Read more »

Episode 317: Listener questions and some questionable answers – PART II

In episode 317, James and Mike continue with their question and answering quest. We offer our spin on cardiovascular risk assessment, prostate screening, creatinine clearance and at the end leave our listeners questioning our podcast.

Show notes

1) Bridge Over Diagnosis - a parody of Bridge Over Troubled Water Read more »

Episode 316: Listener questions and some questionable answers

In episode 316, James and Mike finally get to the back-log of listener questions. We talk about stats, risk factors, guidelines and of course what podcast wouldn’t be complete without mentioning statins. 

Show notes

1) Critical appraisal by and for dummies – three podcast episodes Read more »

Episode 315: A way to think about antidotes for anticoagulants - PART II

In episode 315, James, Mike and Peter Loewen finish talking about the whole issue of antidotes for anticoagulants. In this podcast we focus on how we can have the conversation about these products with patients to allow for as much as possible, shared decision-making.

Show notes

Slides from Peter Loewen’s talk Read more »

Episode 314: A way to think about antidotes for anticoagulants

In episode 314, James and Mike welcome Peter Loewen back to the podcast to help us think through how we should frame the whole issue around antidotes for anticoagulants. At the end, we realise it is much more than just do we or do we not have an antidote.

Show notes

Slides from Peter Loewen’s talk Read more »

Episode 313: COPD studies - All I need is the air that I breathe

In episode 313, James and Mike go over two new large COPD trials that looked at the use of different types of inhalers and find that unfortunately they do very little to clinically relevant outcomes. The bottom line is don’t smoke.

Show notes

1) SUMMIT trial - Fluticasone furoate and vilanterol Read more »

Episode 312: PREMIUM – 4 new studies that you need to know about

In episode 312, Mike and James give you PREMIUM information on high dose Vit D, delayed antibiotics, spironolactone and pioglitazone. All this new evidence supports pretty much all the premium stuff we’ve been saying for years – thank goodness.

Show notes

1) Vitamin D

JAMA Intern Med 2016;176:175-83 Read more »